Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Retrospective pharmacogenetic analysis of a pediatric patient under anticoagulant treatment: Clinical case

Biomedica : revista del Instituto Nacional de Salud - 22 Sept 2021

Cavieres Mirta, Suárez Marcelo, Verón Gabriel, Quiñones Luis Abel, Varela Nelson Miguel

Abstract excerpt

We present the clinical case of a 10-year-old patient diagnosed with dilated cardiomyopathy who registered INR values above 10 upon receiving standard doses of acenocoumarol, as well as other values reported as uncoagulable, forcing the discontinuation and restart of treatment more than once. Expected and stable INR levels were achieved after more than 30 days of treatment, surprisingly with half the recommended...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Pharmacogenomic Testing

Share to Polymorphism, Single Nucleotide

Share to Vitamin K Epoxide Reductases

Source

Open in PubMed Open full text

Identifiers

PMID: 34559488
DOI: 10.7705/biomedica.5840
PMCID: PMC8519589

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Retrospective pharmacogenetic analysis of a pediatric patient under anticoagulant treatment: Clinical casePMID 34559488Read ↗

The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study.Semantic proximity Read ↗

Pharmacogenetics role in the safety of acenocoumarol therapy.Semantic proximity Read ↗

A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort StudySemantic proximity Read ↗

Current pharmacogenetic developments in oral anticoagulation therapy: the influence of variant VKORC1 and CYP2C9 alleles.Semantic proximity Read ↗

[Pharmacogenomics of vitamin K antagonists].Semantic proximity Read ↗

[The pharmacogenetics of vitamin K antagonists: still a matter for discussion].Semantic proximity Read ↗

Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users.Semantic proximity Read ↗

Pharmacogenetics aspects of oral anticoagulants therapy.Semantic proximity Read ↗

VKORC1 pharmacogenomics summary.Semantic proximity Read ↗

A disproportionate analysis of novel oral anticoagulants in the overall and pediatric populations: a pharmacovigilance study based on FDA Adverse Event Reporting System databaseSemantic proximity Read ↗

French‐Speaking Network of Pharmacogenetics ( RNPGx ) Recommendations for Clinical Use of MavacamtenSemantic proximity Read ↗

Can pharmacogenetics help patients under chronic treatment with coumarin anticoagulants?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.